Moscow-based VIVAX entered the Kazakhstan market
2020-10-27 03:15

Moscow-based VIVAX entered the Kazakhstan market

Manufacturer of various innovative peptide technologies VIVAX expanded the export potential of the company and entered the market of Kazakhstan. The products can be purchased in the local retail chain "Novaya Era".

Novaya Era" trading network is the company with the widest range of peptide bioregulators, peptide cosmetics and phytoproducts in Kazakhstan.

Export of VIVAX

At the moment the company products are widely represented in domestic market: St. Petersburg, Yekaterinburg, Irkutsk, Kazan, Kemerovo, Krasnodar, Nizhny Novgorod, Novosibirsk, Perm, Pyatigorsk, Rostov-on-Don, Samara, Simferopol, Sochi, Stavropol, Tyumen, Ufa, Chelyabinsk.

Earlier VIVAX primarily worked with the B2B segment - it was sold in pharmacy chains, dental clinics, gyms, massage parlors. At the moment, more than 700 enterprises all over Russia have become partners of the company. In 2018, VIVAX started developing B2C segment in online mode - the company's store was launched, the products are also sold on the platforms of the leading marketplaces of the country.

Despite its stable position in the domestic market, VIVAX is actively developing the company's export potential - the annual turnover since 2017 has tripled - up to 6 million rubles.

Currently, the company's products are represented in Ukraine and Kazakhstan. And from 2019 VIVAX is presented on the largest international B2B platform Alibaba.

In addition, in 2019, VIVAX participated in the international medical exhibition in Germany - MEDICA 2019 as part of the stand of Moscow companies under the auspices of the Moscow Export Center. In 2020, VIVAX was selected as part of companies to participate in the prestigious accelerator from PwC and IETC to enter the South Korean market. This measure also has a positive impact on the development of the company's export potential.

Strengthening of positions in the CIS markets, as well as entering new markets in non-CIS countries is one of the main directions of the company's development. Already now management of VIVAX actively negotiates with representatives of potential customers from Europe, Middle East, and CIS countries.

In addition, at this time VIVAX is working to expand the company's product range, which is planned to be actively promoted, including the pharmaceutical market. The development of sales in this sector involves the creation of new jobs, as well as a number of measures for the support and promotion of VIVAX products.

"Due to the negative impact on all areas of the economy, restrictive measures relating to COVID-19, the management has reviewed the terms of collaboration with existing and potential partners, the introduction of which will allow a flexible approach to working with each of them," said Andrei Sorokin, founder of VIVAX.

About the company

Based in Moscow, Russia, VIVAX develops various innovative peptide technologies which are able to increase vitality, reduce the likelihood of disease, and improve the function of virtually all human organs and systems.

Products

All VIVAX products are subject to annual certification.

At the moment, VIVAX is represented in the market by three product lines:

- -treatment and prophylactic oral products in the form of toothpaste and rinse balm (VIVAX Dent): help for exacerbations (pink line), increase enamel protection (blue line), daily use (green line).

-Revitalizing and preventive body care (VIVAX Sport): warming cream (red line), relaxing gel (blue line), regenerating cream (green line).

-For body sculpting/anticellulite products (VIVAX Active Slim): slimming anti-cellulite cream and gel (orange line).

Sponsorship

In addition to the development of peptide technologies, VIVAX is an active sponsor of significant sporting events.

For example, in 2013 the company was the sponsor of "Bering-2013" project - 66 sportsmen from 16 countries swam across the Bering Strait for six days without special equipment along the route from Chukotka (Russia) to Alaska (USA). The project was subsequently entered in the Guinness Book of World Records.

A film crew from VIVAX SPORT Studio recorded the future Guinness World Record. The edited documentary, produced by VIVAX founder Andrey Sorokin, was shown at the Pacific Meridian International Film Festival and won the Audience Contest.

In addition, in 2019, VIVAX sponsored the extreme sports project "La Perouse Strait 2019". Evgeny Novozheev, a four-time Russian kitesurfing champion, covered the 53-kilometer route from Sakhalin Island, Russia, to Hokkaido Island, Japan, on a kiteboard. Novozheev became the first kiteboarder to cross the La Perouse Strait, thus setting a world record. The VIVAX SPORT STUDIO film crew filmed the historic moment.